Gilder Gagnon Howe & Co’s Dianthus Therapeutics DNTH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-44,076	Closed	-$994K	–	250
2022 Q3	$994K	Sell	44,076 -2,548	-5%	-$69.8K	0.02%	198
2022 Q2	$895K	Sell	46,624 -164,867	-78%	-$4.07M	0.02%	203
2022 Q1	$9.81M	Sell	211,491 -18,235	-8%	-$996K	0.09%	142
2021 Q4	$16.3M	Sell	229,726 -5,946	-3%	-$598K	0.09%	151
2021 Q3	$27.5M	Sell	235,672 -20,735	-8%	-$2.42M	0.14%	135
2021 Q2	$40.1M	Sell	256,407 -5,431	-2%	-$998K	0.2%	120
2021 Q1	$49.6M	Sell	261,838 -1,800	-0.7%	-$303K	0.27%	100
2020 Q4	$33.1M	Sell	263,638 -2,942	-1%	-$334K	0.16%	125
2020 Q3	$29M	Sell	266,580 -4,276	-2%	-$507K	0.18%	119
2020 Q2	$32.5M	Buy	270,856 +17,119	+7%	+$2.41M	0.25%	98
2020 Q1	$25.5M	Sell	253,737 -2,727	-1%	-$505K	0.31%	92
2019 Q4	$62.2M	Sell	256,464 -2,703	-1%	-$505K	0.65%	57
2019 Q3	$42.5M	Sell	259,167 -1,645	-0.6%	-$312K	0.49%	66
2019 Q2	$61.6M	Buy	260,812 +146,485	+128%	+$36.2M	0.62%	58
2019 Q1	$30.1M	Buy	+114,327	New	+$19.7M	0.32%	80